vimarsana.com

Page 105 - புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Orphazyme appoints Christophe Bourdon as Chief Executive Officer

Aegon closes the sale of Stonebridge

Innova Medical Group Announces New Chairman and Chief Medical Officer

Press release content from PR Newswire. The AP news staff was not involved in its creation. Innova Medical Group Announces New Chairman and Chief Medical Officer March 1, 2021 GMT PASADENA, Calif., Mar. 1, 2021 /PRNewswire/ Innova Medical Group, Inc., the world’s largest manufacturer of rapid antigen test kits and leader in COVID-19 testing solutions globally, announced today the appointment of Sean Rogers as Chairman of Innova Medical Group, and Todd Malan, M.D., as Innova’s Chief Medical Officer. The two seasoned leaders will be valuable additions to Innova’s continued growth in screening and diagnostic test production and distribution, as well as its expanding partnerships with health authorities around the world to help break the COVID-19 chain of transmission and end the deadly pandemic through widespread testing for home screening and clinical diagnostics.

Medexus Achieves Record Revenue of $31 5 Million for the Third Quarter Fiscal 2021

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021 Medexus Pharmaceuticals IncMarch 1, 2021 GMT TORONTO, CHICAGO and MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced its financial and operating results for the three and nine months ended December 31, 2020. All dollar amounts below are in Canadian dollars unless specified otherwise. Third Quarter Fiscal 2021 Financial Highlights: The Company achieved record revenue of $31.5 million for the three-month period ended December 31, 2020, versus $16.2 million for the same period last year. As previously reported, the revenue for the period included approximately $3 million in IXINITY® revenues, which were originally expected to be realized in September 2020, but were instead realized in

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.